GSK sees earnings rise amid good demand for vaccines
October 26, 2016 at 08:03 AM EDT
Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.
